1-7 of 7
Sylvain Thépot
Close
Sort by
Journal Articles

Azacytidine (AZA) in MDS (including RAEB-t and CMML) in Patients (pts) ≥ 80 Years: Results of the French ATU Program.

Raphael Itzykson, Sylvain Thépot, Bechir Achour, Bruno Quesnel, Francois Dreyfus, MD, PhD, Pascal Turlure, MD, Anne-Laure Taksin, MD, Norbert Vey, MD, Anne Marfaing Koka, Stephane de Botton, MD, PhD, Eric Wattel, MD, PhD, Francoise Isnard, Isabelle Plantier, Caroline Dartigeas, Chahinez Zerhouni, Claude Gardin, Lionel Ades, MD, Odile Beyne-Rauzy, MD, PhD, Pierre Fenaux
Journal: Blood
Blood (2009) 114 (22): 1773.
https://doi.org/10.1182/blood.V114.22.1773.1773
Published: 2009
Journal Articles

Azacytidine in Refractory or Relapsed AML After Intensive Chemotherapy (IC): Results of the French ATU Program.

Raphael Itzykson, Sylvain Thépot, Christian Recher, Jacques Delaunay, MD, Bruno Quesnel, Francois Dreyfus, MD, PhD, Anne Marfaing Koka, Norbert Vey, Aspasia Stamatoullas, Emmanuel Gyan, MD, Thomas Cluzeau, Philippe Rousselot, MD, PhD, Oumedaly Reman, Isabelle Plantier, Jean Pierre Marolleau, MD, Pierre Morel, MD, Eric Wattel, MD, PhD, Sorin Visanica, MD, Chahinez Zerhouni, Dominique Bordessoule, Lionel Ades, MD, Pierre Fenaux, Claude Gardin
Journal: Blood
Blood (2009) 114 (22): 1054.
https://doi.org/10.1182/blood.V114.22.1054.1054
Published: 2009
Journal Articles

Azacytidine (AZA) as First Line Therapy in AML: Results of the French ATU Program.

Sylvain Thépot, Raphael Itzykson, Valerie Seegers, Christian Recher, Bruno Quesnel, Jacques Delaunay, MD, Thomas Cluzeau, Anne Marfaing Koka, Aspasia Stamatoullas, MP Chaury, Caroline Dartigeas, Stéphane Cheze, Celia Salanoubat, Pierre Morel, MD, Isabelle Plantier, Anne-Laure Taksin, MD, Jean Pierre Marolleau, MD,, Cecile Pautas, MD, Eric Wattel, MD, PhD, Francoise Isnard, Laurence Sanhes, Stephanie Harel, Stephane de Botton, MD, PhD, Yasmine Chait, Madalina Uzunov, Agnes Guerci, MD, PhD, Mehdi Dahoun, Norbert Vey, MD, PhD,, Herve Dombret, MD, PhD,, Francois Dreyfus, MD, PhD, Lionel Ades, MD,, Pierre Fenaux, Claude Gardin
Journal: Blood
Blood (2009) 114 (22): 843.
https://doi.org/10.1182/blood.V114.22.843.843
Published: 2009
Journal Articles

Prognostic Factors of Response and Overall Survival (OS) in Higher-Risk MDS (including RAEB-t) Treated with Azacytidine (AZA): Results of the French ATU Program.

Raphael Itzykson, Sylvain Thépot, Bruno Quesnel, Odile Beyne-Rauzy, MD, PhD, Francois Dreyfus, MD, PhD, Norbert Vey, MD, Pascal Turlure, MD, Laurence Legros, Caroline Dartigeas, Jacques Delaunay, MD, Stephane de Botton, MD, PhD, Emmanuel Raffoux, MD, Anne-Laure Taksin, MD, Aspasia Stamatoullas, Anne Marfaing Koka, Eric Wattel, MD, PhD, Sorin Visanica, MD, Célia Salanoubat, Pierre Morel, MD, Pascale Cony Makhoul, Stéphane Cheze, Laurence Sanhes, Isabelle Plantier, Gerard Tertian, Mehdi Dahoun, Agnes Guerci, MD, PhD, Claude Gardin, Lionel Ades, MD, Pierre Fenaux
Journal: Blood
Blood (2009) 114 (22): 3820.
https://doi.org/10.1182/blood.V114.22.3820.3820
Published: 2009
Journal Articles

Response to Azacytidine (AZA) in MDS or AML with Del 5q : Current Results of the French ATU Program

Raphael Itzykson, Sylvain Thépot, Claire Fabre, Francois Dreyfus, Bruno Quesnel, Eric Wattel, Stephane de Botton, Sylvain Pilorge, Caroline Dartigeas, Aspasia Stamatoullas, Thomas Prebet, Mario Ojeda-Uribe, Stéphane Cheze, Olivier Tournilhac, Eric Solary, Gandhi Damaj, Gerard Tertian, Chantal Himberlin, Rose-Marie Mbida, Blandine Beve, Lionel Adès, Claude Gardin, Pierre Fenaux
Journal: Blood
Blood (2008) 112 (11): 2682.
https://doi.org/10.1182/blood.V112.11.2682.2682
Published: 2008
Journal Articles

Treatment of Progression of Myeloproliferative Disorders(MPD) to MDS/AML by Azacytidine (AZA) : A Preliminary Report on 17 Patients (pts)

Sylvain Thépot, Raphael Itzykson, Emmanuel Raffoux, Murielle Roussel, Caroline Dartigeas, Francois Dreyfus, Christian Recher, Sylvain Pilorge, Bruno Cassinat, Blandine Beve, Rose-Marie Mbida, Jean-Jacques Kiladjian, Lionel Ades, Pierre Fenaux
Journal: Blood
Blood (2008) 112 (11): 2800.
https://doi.org/10.1182/blood.V112.11.2800.2800
Published: 2008
Journal Articles

Core Binding Factor Acute Myeloid Leukemia of the Elderly Treated with Conventional Chemotherapy: A Collaborative Study of the French CBF AML Intergroup

Thomas Prebet, MD, Nicolas Boissel, MD, PhD, Christian Recher, MD, PhD, Xavier Thomas, MD, PhD, Jacques Delaunay, MD, Jean-Yves Cahn, MD, PhD, Arnaud Pigneux, MD, PhD, Bruno Quesnel, MD, PhD, Francis Witz, MD, Sylvain Thépot, Valérie Ugo, MD, Christine Terre, Emmanuelle Tavernier, MD, PhD, Sylvie Castaigne, MD, Francois Guilhot, MD, Hervé Dombret, Norbert Vey, MD
Journal: Blood
Blood (2008) 112 (11): 553.
https://doi.org/10.1182/blood.V112.11.553.553
Published: 2008